IN2012DN04966A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN04966A IN2012DN04966A IN4966DEN2012A IN2012DN04966A IN 2012DN04966 A IN2012DN04966 A IN 2012DN04966A IN 4966DEN2012 A IN4966DEN2012 A IN 4966DEN2012A IN 2012DN04966 A IN2012DN04966 A IN 2012DN04966A
- Authority
- IN
- India
- Prior art keywords
- medicaments
- compounds
- formula
- group
- description
- Prior art date
Links
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0905953A FR2953521B1 (fr) | 2009-12-09 | 2009-12-09 | Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2010/000823 WO2011070253A1 (fr) | 2009-12-09 | 2010-12-08 | Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN04966A true IN2012DN04966A (cs) | 2015-09-25 |
Family
ID=42711699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4966DEN2012 IN2012DN04966A (cs) | 2009-12-09 | 2010-12-08 |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20120283245A1 (cs) |
| EP (1) | EP2509947A1 (cs) |
| JP (1) | JP2013513589A (cs) |
| KR (1) | KR20120102763A (cs) |
| CN (1) | CN102652127A (cs) |
| AP (1) | AP2012006352A0 (cs) |
| AR (1) | AR079265A1 (cs) |
| AU (1) | AU2010329762B2 (cs) |
| BR (1) | BR112012013666A2 (cs) |
| CA (1) | CA2782469C (cs) |
| CL (1) | CL2012001479A1 (cs) |
| CO (1) | CO6541535A2 (cs) |
| CR (1) | CR20120286A (cs) |
| CU (1) | CU20120091A7 (cs) |
| EA (1) | EA201200849A1 (cs) |
| EC (1) | ECSP12011950A (cs) |
| FR (1) | FR2953521B1 (cs) |
| GE (1) | GEP20156227B (cs) |
| IN (1) | IN2012DN04966A (cs) |
| MA (1) | MA33882B1 (cs) |
| MX (1) | MX2012006578A (cs) |
| NI (1) | NI201200099A (cs) |
| PE (1) | PE20121475A1 (cs) |
| PH (1) | PH12012501053A1 (cs) |
| SA (1) | SA110320011B1 (cs) |
| SG (1) | SG181082A1 (cs) |
| TN (1) | TN2012000267A1 (cs) |
| TW (1) | TW201200499A (cs) |
| UA (1) | UA102950C2 (cs) |
| UY (1) | UY33072A (cs) |
| WO (1) | WO2011070253A1 (cs) |
| ZA (1) | ZA201203943B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105764510A (zh) * | 2013-09-09 | 2016-07-13 | 赛诺菲 | H3受体拮抗剂与胆碱酶抑制剂组合用于阿尔茨海默氏病治疗中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0507680D0 (en) * | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
| BRPI0619233A2 (pt) * | 2005-11-30 | 2011-09-20 | Hoffmann La Roche | compostos, processo para a sua manufatura, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, uso dos compostos e método para o tratamento ou prevenção de obesidade e de diabetes do tipo ii em um ser humano ou animal |
-
2009
- 2009-12-09 FR FR0905953A patent/FR2953521B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-01 UY UY0001033072A patent/UY33072A/es unknown
- 2010-12-03 TW TW099142190A patent/TW201200499A/zh unknown
- 2010-12-06 AR ARP100104484A patent/AR079265A1/es not_active Application Discontinuation
- 2010-12-07 SA SA110320011A patent/SA110320011B1/ar unknown
- 2010-12-08 IN IN4966DEN2012 patent/IN2012DN04966A/en unknown
- 2010-12-08 AU AU2010329762A patent/AU2010329762B2/en not_active Ceased
- 2010-12-08 MX MX2012006578A patent/MX2012006578A/es active IP Right Grant
- 2010-12-08 EA EA201200849A patent/EA201200849A1/ru unknown
- 2010-12-08 UA UAA201208178A patent/UA102950C2/ru unknown
- 2010-12-08 EP EP10799080A patent/EP2509947A1/fr not_active Withdrawn
- 2010-12-08 PH PH1/2012/501053A patent/PH12012501053A1/en unknown
- 2010-12-08 PE PE2012000722A patent/PE20121475A1/es not_active Application Discontinuation
- 2010-12-08 KR KR1020127017843A patent/KR20120102763A/ko not_active Ceased
- 2010-12-08 MA MA34932A patent/MA33882B1/fr unknown
- 2010-12-08 BR BR112012013666A patent/BR112012013666A2/pt not_active IP Right Cessation
- 2010-12-08 AP AP2012006352A patent/AP2012006352A0/xx unknown
- 2010-12-08 WO PCT/FR2010/000823 patent/WO2011070253A1/fr active Application Filing
- 2010-12-08 GE GEAP201012774A patent/GEP20156227B/en unknown
- 2010-12-08 US US13/514,796 patent/US20120283245A1/en not_active Abandoned
- 2010-12-08 CA CA2782469A patent/CA2782469C/fr not_active Expired - Fee Related
- 2010-12-08 SG SG2012038931A patent/SG181082A1/en unknown
- 2010-12-08 CN CN2010800559947A patent/CN102652127A/zh active Pending
- 2010-12-08 JP JP2012542591A patent/JP2013513589A/ja not_active Ceased
-
2012
- 2012-05-28 TN TNP2012000267A patent/TN2012000267A1/fr unknown
- 2012-05-29 CR CR20120286A patent/CR20120286A/es unknown
- 2012-05-30 ZA ZA2012/03943A patent/ZA201203943B/en unknown
- 2012-06-05 EC ECSP12011950 patent/ECSP12011950A/es unknown
- 2012-06-06 CL CL2012001479A patent/CL2012001479A1/es unknown
- 2012-06-06 CO CO12095636A patent/CO6541535A2/es unknown
- 2012-06-07 CU CU20120091A patent/CU20120091A7/es unknown
- 2012-06-07 NI NI201200099A patent/NI201200099A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502300A1 (en) | Pesticidal compositions and processes related thereto | |
| MX341133B (es) | Compuestos y metodos para la inhibición de hdac. | |
| UA107791C2 (en) | Pesticidal compositions | |
| UA106748C2 (uk) | Похідні проліну як інгібітори катепсину | |
| IN2012DN02092A (cs) | ||
| IN2014DN00176A (cs) | ||
| MY162780A (en) | N-(Tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamides and use thereof as herbicides | |
| PH12013500886A1 (en) | Pesticidal compositions and processes related thereto | |
| MY162411A (en) | Crystalline forms of a macrolide, and uses therefor | |
| MX2010006143A (es) | Azolilmetiloxiranos, su uso y agentes que lo contienen. | |
| MX2012008141A (es) | Compuestos y metodos. | |
| MY161132A (en) | Novel herbicides | |
| MX2011007998A (es) | Nuevos herbicidas. | |
| MX342913B (es) | Formas solidas de romidepsina y sus usos. | |
| MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
| MX2011007932A (es) | Herbicidas nuevos. | |
| MX2009010103A (es) | Composiciones estructuradas que comprenden una arcilla. | |
| MX2012014796A (es) | Proceso para preparar 4-hidroxipiridinas. | |
| MY149154A (en) | Novel microbiocides | |
| MX2009010903A (es) | Metodos para preparar compuestos basados en imidazol. | |
| IN2014DN10669A (cs) | ||
| MX346090B (es) | Derivados de pirrolidina usados como inhibidores de catepsina. | |
| MX2012005155A (es) | Compuestos de quinazolina. | |
| MX349563B (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
| IN2012DN01223A (cs) |